Search

Your search keyword '"Rimonabant -- Dosage and administration"' showing total 8 results
Start Over Descriptor "Rimonabant -- Dosage and administration" Language english
8 results on '"Rimonabant -- Dosage and administration"'

1. Study Results from State University Santa Cruz Broaden Understanding of Pharmacology (Context-dependent effects of the CB1 receptor antagonist rimonabant on morphine-induced behavioral sensitization in female mice)

Subjects
Prevention, Risk factors, Methods, Dosage and administration, Rimonabant -- Dosage and administration, Pharmacology -- Methods, Opioid abuse -- Risk factors -- Prevention, Neurophysiology -- Methods
Abstract

2023 FEB 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New study results on pharmacology have been published. According to news reporting [...]

Published
2023

2. Findings from University of Szeged Advance Knowledge in Antioxidants (Potential Implications of Rimonabant on Age-Related Oxidative Stress and Inflammation)

Subjects
Diagnosis, Care and treatment, Analysis, Risk factors, Dosage and administration, Health aspects, Rimonabant -- Dosage and administration, Tumor necrosis factor -- Analysis, Oxidative stress -- Health aspects, Cardiovascular diseases -- Risk factors -- Diagnosis -- Care and treatment
Abstract

2022 FEB 12 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in antioxidants. According to news originating from Szeged, [...]

Published
2022

3. Researchers from Max-Planck-Institute for Psychiatry Report Details of New Studies and Findings in the Area of Obesity (The Cannabinoid Cb1 Antagonist Tm38837 With Limited Penetrance To the Brain Shows Reduced Fear-promoting Effects In Mice)

Subjects
Research, Care and treatment, Psychological aspects, Dosage and administration, Obesity -- Research -- Care and treatment -- Psychological aspects, Rimonabant -- Dosage and administration, Novels, Physical fitness, Editors
Abstract

2019 APR 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Nutritional and Metabolic Diseases and Conditions - Obesity have [...]

Published
2019

5. Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program

Author

van Gaal, Luc, Pi-Sunyer, Xavier, Despres, Jean-Pierre, McCarthy, Christine, and Scheen, Andre

Subjects
Drug therapy, Prevention, Dosage and administration, Rimonabant -- Dosage and administration, Metabolic diseases -- Prevention -- Drug therapy, Overweight persons -- Drug therapy, Cardiovascular diseases -- Prevention -- Drug therapy
Abstract

OBJECTIVE--To better define the efficacy and safety of rimonabant, the first selective cannabinoid type 1 (C[B.sub.1) receptor antagonist, in a large population of overweight and obese patients using pooled efficacy [...]

Published
2008

6. Zimulti

Subjects
Zimulti (Medication) -- Dosage and administration, Drug therapy, Dosage and administration, Obesity -- Drug therapy, Rimonabant -- Dosage and administration
Abstract

Rimonabant (Zimulti, Sanofi-Aventis) for weight management in obese and overweight patients with associated risk [...]

Published
2007

7. Rimonabant cuts [HbA.sub.1c], weight in type 2

Author

Bell, John R.

Subjects
Diagnosis, Care and treatment, Analysis, Dosage and administration, Rimonabant -- Dosage and administration, Type 2 diabetes -- Diagnosis -- Care and treatment, Body weight -- Analysis
Abstract

New data on rimonabant suggest that the selective endocannabinoid type 1-receptor blocker has beneficial effects on glycemic control and other risk factors in diabetic patients. In treatment-naive patients with type [...]

Published
2006

8. PulseClinical: New drug therapies

Subjects
Drug therapy, Dosage and administration, Glucagon -- Dosage and administration, Rimonabant -- Dosage and administration, Thiazolidinediones -- Dosage and administration, Type 2 diabetes -- Drug therapy
Abstract

Recent years have seen a raft of new therapeutic modalities for type 2 diabetes. Professor Anthony Barnett outlines the role of the latest drug therapies Although metformin is likely to [...]

Published
2006

Catalog

Books, media, physical & digital resources
See catalog results